Do SARS-CoV-2-Infected Pregnant Women Have Adverse Pregnancy Outcomes as Compared to Non-Infected Pregnant Women?

To determine the feto-maternal outcome in pregnant women infected with SARS-CoV-2 in comparison to non-infected pregnant women and plan management strategies. A retrospective review of case records in the Department of Obstetrics and Gynecology for 1 year was conducted. A total of 6468 case files fu...

Full description

Saved in:
Bibliographic Details
Published in:International journal of women's health 2022-01, Vol.14, p.1201-1210
Main Authors: Ahmad, Syed Nawaz, Sameen, Duri, Dar, Mansoor Ahmad, Jallu, Romaan, Shora, Tajali Nazir, Dhingra, Mansi
Format: Article
Language:English
Subjects:
cesarean
Cesarean section
Comparative analysis
Coronaviruses
COVID-19
covid19
Cytokines
Diabetes
Disease transmission
icu
Infant mortality
Infants
Infections
Intensive care
maternal
Maternal mortality
Medical research
Medicine, Experimental
Morbidity
mortality
Mothers
neonatal
Neonatal intensive care
Newborn babies
Obstetrics
Original Research
Patient outcomes
Patients
Pneumonia
Pregnancy
Pregnant women
Respiratory diseases
Severe acute respiratory syndrome coronavirus 2
Viruses
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine the feto-maternal outcome in pregnant women infected with SARS-CoV-2 in comparison to non-infected pregnant women and plan management strategies. A retrospective review of case records in the Department of Obstetrics and Gynecology for 1 year was conducted. A total of 6468 case files fulfilling the inclusion criteria were enrolled in the study. Patients who tested positive for SARS CoV-2 and fulfilled inclusion criteria were labeled as cases, whereas patients who tested negative were labeled as controls. Outcome measures including lower segment cesarean section (LSCS) rate, maternal and neonatal intensive care admission and feto-maternal mortality were compared between the two groups. Our hospital was not an exclusive COVID-19 designated center, and 117 patients infected with SARS-CoV-2 fulfilling the inclusion criteria were enrolled in the study. Fever (67.52%), cough (56.41%), and altered smell (45.29%) were the frequently reported symptoms. Pneumonia affected 16.23% of the cases. LSCS rate was significantly higher in the COVID-19-infected patients (72.41%; OR 2.19; 95% CI 1.46-3.34; p
ISSN:1179-1411
1179-1411
DOI:10.2147/IJWH.S375739